Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review

S Alshahrani - Frontiers in Pharmacology, 2023 - frontiersin.org
Chronic kidney disease presents a health challenge that has a complex underlying
pathophysiology, both acquired and inherited. The pharmacotherapeutic treatment options …

New horizons for stroke prevention: PROGRESS and HOPE

PB Gorelick - The Lancet Neurology, 2002 - thelancet.com
Inhibitors of angiotensin-converting enzyme (ACE) act by blocking the conversion of
angiotensin I to angiotensin II, which is catalysed by this enzyme. ACE inhibitors also …

Perindopril: an updated review of its use in hypertension

M Hurst, B Jarvis - Drugs, 2001 - Springer
Perindopril erbumine (perindopril) is a prodrug ester of perindoprilat, an angiotensin
converting enzyme (ACE) inhibitor. Perindopril 4 to 8mg once daily significantly reduces …

Research trends in contemporary health economics: a scientometric analysis on collective content of specialty journals

CC Zwack, M Haghani, EW de Bekker-Grob - Health Economics Review, 2024 - Springer
Introduction Health economics is a thriving sub-discipline of economics. Applied health
economics research is considered essential in the health care sector and is used …

Capillary zone electrophoresis applied to the determination of the angiotensin-converting enzyme inhibitor cilazapril and its active metabolite in pharmaceuticals and …

JA Prieto, U Akesolo, RM Jiménez… - Journal of Chromatography …, 2001 - Elsevier
A capillary zone electrophoresis method has been developed for the quantitation of
antihypertensive drug cilazapril and its active metabolite cilazaprilat in pharmaceuticals and …

Cost-effective strategies in the prevention of diabetic nephropathy

JD Rippin, AH Barnett, SC Bain - Pharmacoeconomics, 2004 - Springer
A significant subgroup of patients with diabetes mellitus are predisposed to developing
diabetic nephropathy and it is in this subgroup that other diabetesrelated complications, and …

Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors

C Bourgault, E Elstein, J Le Lorier, S Suissa - CMAJ, 1999 - Can Med Assoc
Background: Reference-based pricing is a cost-containment policy applied to prescription
drugs that are in the same class and deemed to be therapeutically equivalent. Recent …

Description and analysis of the VA National Formulary

R Herdman, D Blumenthal - 2000 - books.google.com
The VA National Formulary generated controversy, which motivated congressional scrutiny
and a directive to the VA to commission this report reviewing the experience with the …

Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?

S Ruland, PB Gorelick - Current atherosclerosis reports, 2003 - Springer
Statins and angiotensin-converting enzyme (ACE) inhibitors are an important component of
our armamentarium for stroke prevention. Both of these classes of agents have a primary …

[PDF][PDF] Hypertension and common complications-analysis of the ambulatory treatment cost

AD Ivanova, GI Petrova - Central European journal of public health, 2009 - researchgate.net
Aim: Retrospective analysis of the prescribing practice and cost of ambulatory treatment of
hypertension and its common complications–heart failure, sequelae of cerebrovascular …